Countable Labs Sets a New Standard in Molecular Testing for Hematologic Malignancy Clinical Applications

PALO ALTO, Calif.–(BUSINESS WIRE)– #AMP2026–Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company’s entry into clinical markets.